Perforin/granzyme B-and Fas/FasL-mediated killing pathways are the main effector mechanisms of CTL and NK cells in antitumor immune responses. In this study, we investigated the relative role of these two lytic mechanisms in protection of the host from tumor progression, as well as spontaneous metastasis, using the D122 Lewis lung carcinoma and its gene-modified cells. Utilizing perforin knockout mice (B6-PKO) and Fas and FasL mutant (B6-MRL and B6-Smn) mice, we found that perforin expression in the host plays a crucial function in the prevention of metastasis. However, local tumor rejection of an H-2K b and B7-1 transfectant, 39.5-B7 cells,
C ytotoxic T cells (CTLs) and natural killer (NK) cells are the major effectors in tumor surveillance. CTL have to recognize their target cells by associating their Tcell receptor (TCR) with MHC/peptide complexes on the target cells as signal 1. Besides this signal 1, costimulation signal interactions between receptors, for example CD28 on CTL and their ligand, B7-1 (CD80) on antigenpresenting cells (APCs) can provide additional signals to fully activate T cells. These second signals can modulate the production of various lymphokines/cytokines, such as IL-2, 1 enhance survival of activated T cells 2 and regulate cell-cycle progression. These activated CTL 3 can proliferate vigorously and then differentiate into effector cells to eliminate target cells. It is known that perforin/ granzyme and Fas/FasL-mediated killing pathways are the main mechanisms of effectors to eliminate target cells, like transformed cells. [3] [4] [5] In the absence of these cytolytic functions, gIFN and TNF-a are also responsible for the antitumor effects of immunocytes. [6] [7] [8] Granules containing the pore-forming protein perforin and granzymes, which are serine proteinases, are released from CTL to target cells that undergo apoptosis. 9 In addition, besides granule-mediated killing, interaction of death receptors, such as Fas on the target cells with their ligand, FasL on CTL can also induce apoptosis by activation of cystein proteinase, 5 the caspase cascades. 10 Recently, a new member of the TNF family, TNF-related apoptosis-inducing ligand (TRAIL) was shown to play an important role in antitumor effects of immune cells. Although caspase activation is essentially required to transmit apoptotic signals, 11, 12 certain target cells can also be induced to undergo apoptosis by caspase-independent lytic mechanisms. 13, 14 However, the relative importance of perforin and Fas/FasL-mediated cytolytic functions has not been well demonstrated in vivo.
Antitumor vaccines strategies broadly rely on using tumor-associated antigens and their peptides, or genemodified (GM-CSF, IL-2, IL-12, etc) tumor cells. 15, 16 Our group has reported that transfection of H2-K b into Lewis lung carcinoma derived D122 cells, which are low immunogenic and high metastatic, abolished their metastatic phenotype. In addition, immunization with H-2K b transfectants provoked protective immunity mediated through CD8 T cells against parental D122 tumor cells, indicating that CTL were the main effectors that protect the host from metastasis. 17 In the present study, we tested how perforin and Fas/ FasL expression by the host affects tumorigenicity and immunogenicity of parental D122, the H-2K b transfectant (39.5.1.11) and the B7-1-expressing K b transfectant (39.5-B7) in order to study their ability to elicit antitumor immune responses and their susceptibility to various killing mechanisms of CTL and NK cells. We found that CD8 CTL played a major role in rejecting 39.5-B7 local tumors. 39.5-B7 cell lysis by CTL was induced by mechanisms that are dependent on caspases activation, but not mediated through perforin, Fas/FasL or cytokine cytotoxicity.
Materials and methods

Mice
C57BL/6-Pfp tm1sdz (PKO), B6-MRL-Fas lpr (B6-lpr/lpr) and B6-Smn.C3H-Fasl gld (B6-gld/gld) mice were all purchased from The Jackson Laboratory (Bar Harbor, ME) and confirmed in impairment of perforin gene, Fas and FasL mutation by RT-PCR based on published data (Data not shown). 4, 18, 19 Mice used for the experiments were generally 8-12 weeks old and were maintained in the animal facility of the Weizmann Institute of Science.
Tumor cells
The highly metastatic and low immunogenic D122 clone of the C57BL/6-derived Lewis lung carcinoma, H-2K b transfected D122 cells (39.5. 1.11), H-2K b and B7-1(CD80) transfected clone 39.5-B7 were used in these experiments. Murine gIFN transduced D122 clones, NAT.A (nonsecretor of gIFN), DIF-2 (high secretor of gIFN), 20 human IL-6 transfected D122 clone, DIL6-7, human IL-2 transduced D122, DIL2-102, murine IL-12 transfectant BD9, murine GM-CSF D122 transfectant, DG4, were used in apoptotic assays or RT-PCR experiments. 21 The cells were maintained in DMEM supplemented with 10% heat-inactivated fetal bovine serum (FBS: GIBCO BRL, Paisley, Scotland), 50 mg/ml gentamicin, 10 mM sodium pyruvate and nonessential amino acid. Murine Fas receptor transfected L1210 cells (L1210-fas), which were kindly provided by Dr Zelig Eshhar (Weizmann Institute of Science), and Jurkat T-cell lymphoma and A20 a murine B-cell lymphoma were used as positive controls of apoptotic assays or RT-PCR, respectively. These cells were maintained in RPMI 1640 supplemented by 10% heat-inactivated fetal bovine serum and gentamicin (50 mg/ml).
Antibodies and reagents
Recombinant human soluble TRAIL (sTRAIL) kit was purchased from Alex Corporation. These reagents were used for induction of apoptosis in in vitro assays. FITClabeled anti-mouse Fas mAbs (Jo2) were purchased from BD PharMingen (San Diego, CA). Anti-mouse H-2K b (Caltech. Lot-04010404), D b (Lot No. G127-M4787) and CD 80 mAbs (Clone 1G10) labeled FITC (SouthernBiotech, BA) were all used in FACS analyses. A broadspectrum caspsae inhibitor (z-VAD-fmk: BIOMOL Research Laboratories), caspase-8 inhibitor II (z-IETD-fmk) and caspase-9 inhibitor I (z-LEHD-fmk):Calbiochem, SD) were used (stock conc. 50 mM) in CTL inhibition assays.
RT-PCR analysis
Total RNA from tumor cells were isolated using the TRIREAGENT (Molecular Research Center, Cincinnati, OH, USA) according to the manufacturer's instructions. Reverse transcription was performed from 5 mg of total RNA with an oligo d(T) primer. cDNA corresponding to 500 ng of total RNA was amplified under standard condition. For amplification of mouse Fas receptor (mFas), TRAIL receptor (DR5, Accession No. af176833) and GAPDH, primer sequences and annealing temperature (T a ) were used as follows: (1) 
FACS analyses
Parental D122 and the transfectants were washed in phosphate-buffered saline (PBS) and incubated for 30 minutes at 41C with FITC-labeled mAbs, anti-mFas (Jo2), H-2K b , H-2D b and B7-1(CD80). FITC-labeled isotype control antibodies (Jackson Immuno Research) were used as negative controls. Cells were then washed once with PBS containing 0.1% sodium azide and 1% BSA. After washing, the stained cells were analyzed by FACScan (Becton Dickinson, San Jose, CA) and the data through the CellQuest software (Becton Dickinson).
Cell Killing assays
Human FasL transfected D122 cells (39.5-B7-FasL7) and parental cells (39.5-B7) were distributed into flat bottom 96-well plates. These cells were admixed at different ratios with L-[
35 S]methionine parental D122, transfectants and L1210-fas target cells (1 Â 10 5 cells/ml), and incubated for 18 hours at 371C. After 18 hours incubation supernatants (50 ml) were mixed with scintillation fluid and measured in a b-counter. The percentage of specific lysis was calculated as follows: % Lysis ¼ {(experimental { 35 S} release -spontaneous release)/(maximal release -spontaneous release)} Â 100.
Spontaneous and maximum release were determined by incubating target cells with medium alone or with 0.1 N NaOH, respectively.
Detection of apoptosis
Cells were incubated with sTRAIL (100 ng/ml) overnight. After 24 hours, apoptotic cells were detected by flow cytometry after staining with FITC-conjugated Annexin V and propidium iodine (PI) using a commercial kit (Annexin V-FITC Kit: Bender MedSystems, Vienna, Austria).
In vivo tumor growth and spontaneous metastasis
Mice (eight mice in each experimental group) were inoculated intrafootpad (i.f.p.) with 2 Â 10 5 -1 Â 10 6 tumor cells in 50 ml PBS in the right hind leg. Local tumor growth was determined by measuring the diameter of the footpads with calipers. To quantitate spontaneous lung metastasis, tumor-bearing feet were amputated below the knee when the tumors reached 8-9 mm in diameter and the mice were killed 60 days following amputation or monitored daily and killed when mice were moribund. Survival is defined as the number of days until moribund mice were sacrificed. Metastatic load was assayed by weighing the lungs.
NK assays
Mice were injected intraperitoneally (i.p.) with 200 mg Poly I:C (polyinosinic-polycytidylic acid : Sigma) per mouse, in 0.5 ml PBS. After 18 hours, spleens were removed, splenocytes teased and RBC lysed. The splenocytes were washed 2-3 times with PBS and admixed at different ratios with [ 35 S]-methionine target cells. The plates were incubated for 5 hours at 371C, are 5% CO 2 and 50 ml supernatant were collected for counting as a above.
In vitro cytotoxicity assays
Mice were immunized, intraperitoneally with 2 Â 10 6 irradiated (5000 rad) parental D122 cells or transfectants, three times at 7-day intervals. Spleens were taken from immunized mice 10 days after the third booster and restimulated in vitro for 4 days on a monolayer of irradiated (5000 rad) and mitomycin C-treated (80 mg/10 hours. Cultures were terminated by centrifugation at 250 g for 10 minutes at 4 1C, and then 50 ml supernatants were harvested and monitored in a mix with scintillation fluid. Percent-specific lysis was calculated as in the cell killing assay. For the inhibition of perforin-based cytotoxicity, effectors were pretreated with Concanamycin A (CMA:Sigma-Aldrich) for 1 hour at 100 nM, and then CMA-treated effectors were incubated with their target cells for indicated times at 371C, 5% CO 2 .
For the inhibition experiments using various caspase inhibitors, various caspase inhibitors (50 mM) were distributed into 96-well plates containing [ 35 S]-labeled target cells. After pre-incubation for 30 minutes, the plates were added with effector cells. Diluted hybridoma ascites containing specific mAbs (anti-CD8, anti-TNF-a and anti-gIFN) were filtered by a 0.45 mm filter and added into 96-well plates that were distributed with effector cells. Purified rat IgG was used as a negative control for mAb.
Depletion of immunocytes and neutralization of gIFN or TNF-a in vivo
Monoclonal antibodies against CD8 (YTS-169.1:rat mAb, IgG 2b ) were injected to deplete subsets of immune cells. R4-6A2 (rat mAb) against mouse gIFN, and 1F3F3 (rat IgM) against mouse TNF-a 22 were used to neutralize gIFN and TNF-a in vivo, respectively. Mice were injected intravenously (i.v.) with 0.5 ml hybridoma ascites and the following day, tumor cells (2 Â 10 5 cells/mouse) were inoculated into the footpads of the mice. Starting on day 6 after inoculation, mice were injected i.p. with 250 ml of diluted hybridoma ascites weekly until tumor-bearing feet were amputated. Purified rat IgM was injected into parallel groups as control.
Statistical analysis
The significance between the experimental and control groups in all experiments of this study was determined by Student's t-test. Two-tailed P-values of o.05 were considered significant.
Results
Fas-and TRAIL-mediated apoptotic pathways in paretnal D122 and its transfectants
We tested Fas expression on the high metastatic and low immunogenic Lewis lung carcinoma clone D122 cells, and on the H-2K b and B7-1 (CD80) transfectant (39.5-B7) as well as various cytokine transfectants. Fas expression on RNA levels was examined by RT-PCR. Levels of Fas expression were markedly upregulated in NAT.A (gIFN nonsecretor), DIF-2 (gIFN secretor) and DIL6-7 (IL-6 secretor) cells compared to D122 parental cells (Fig 1a) . gIFN secretor, DIF-2 cells showed high Fas expression on the cell surface while D122 cells stained negative. In addition, we observed that Fas expression on 39.5-B7 cells was slightly increased. Enhancement of Fas receptor expression on DIF-2 cells was proportional to the density of the culture and increased with the incubation times (48, 72 and 96 hours) in vitro; however, expression levels of Fas on 39.5-B7 cells did not change with the time of incubation (data not shown). This observation is consistent with reports that gIFN can effectively enhance expression of Fas receptor on the cell surface. 23 Although we could not detect apoptotic death mediated by soluble FasL (sFasL) (1 mg/ml) under various experimental conditions, coincubation with FasL-expressing cells (39.5-B7-FasL) for 18 hours did induce apoptosis of Fas-expressing cells, including L1210-fas as a positive control. FasL nonexpressor (39.5-B7) did not induce apoptosis (Fig 2a) . These results indicate that membranebound FasL can more effectively induce apoptosis in Fasexpressing cells than soluble FasL. 24 Recently, it has been reported that the TRAIL-mediated killing pathway on immune cells also plays an important role in elimination of tumor cells. 25 We tested whether soluble TRAIL would induce apoptotic cell death of parental D122 and cytokine transfectants. RT-PCR results show that the TRAIL receptor, DR5, is expressed in the transfectants, NAT.A, DIF-2 and IL6-7, and is equivalent to that of D122 parental cells, suggesting that cytokines (gIFN, IL-6) do not modulate transcription of TRAIL receptor expression (Fig 2b) . Whereas Jurkat T cells, which are sensitive to sTRAIL, were markedly induced to undergo apoptotic cell death, D122 and the transfectants were not killed during coincubated with sTRAIL (100 ng/ml) for 24 hours (Fig 2c) . Therefore, D122 derivatives, 39.5-B7 and DIF-2, were sensitive to FasL-expressing tumor cells, but not to sTRAIL. Tumor rejection by CTL independent of perforin/FasL S-H Lee et al both transfectants, 39.5.1.11 and 39.5-B7, is remarkably higher than in parental D122 cells. Levels of H-2D b expression of the transfectants are similar to those of parental D122, showing that transfection does not affect H-2D b expression levels of parental D122 cells. We could only observe B7-1 expression in 39.5-B7 cells (Fig 3) . C57BL/6 mice, B6-PKO and Fas/FasL (B6-MRL/Smn) mutant mice were inoculated with D122 and the two transfectants, 39.5.1.11 and 39.5-B7, at various doses (2 Â 10 5 , 5 Â 10 5 and 1 Â 10 6 cells/mouse) and tumor growth followed. Figure 4 shows the results; at the highest inoculum (10 6 cells/mouse), local tumor growth of 39.5.1.11 cells in the mice was not statistically different from that of parental D122 cells. Local tumor progression of parental D122 and 39.5.1.11 cells in syngenic C57BL/6 mice was delayed relative to all mutant mice, indicating that perforin and functional Fas/FasL expression, by the host can influence tumorigenicity in vivo. Notably, 39.5-B7 local tumors were rejected in the mice, including B6-PKO and B6-MRL/Smn mice. Local 39.5-B7 tumors in B6-PKO and B6-MRL/ Smn mice seemed to develop at early stages, but these palpable tumors regressed and were finally rejected 24 days postinoculation. These observations suggest that rejection of 39.5-B7 tumors is not strictly dependent on perforin and Fas/FasL expression by the host (Fig 4) . Furthermore, Table 1 shows that, despite the fact that the tumor growth pattern of 39.5.1.11 cells is similar to that of parental D122 cells, mice inoculated with 39.5.1.11 tumor do not succumb to metastatses. All B6-PKO, 5/8 B6-MRL and 5/8 B6-Smn mice survived until all the D122-bearing mice died of metastases within 30 days after amputation. At 60 days post amputation, lung weights from the surviving mice showed that metastases did not occur in the mice. These results indicate that, although H-2K b expression on the parental D122 cells does not induce reduction of tumorigenicity, their metastatic phenotype is abolished due to expression of H-2K b , in vivo. In addition, both perforin and Fas/FasL expression in the host did not affect their low metastatic phenotype. Survival in B6-PKO mice inoculated with D122 cells was significantly shorter than that of other mouse strains (p value o.0001), indicating that perforin expression by the host plays a major role in the kinetics of spontaneous metastases from D122 local tumors. Survival days were calculated for 3/8 mice that died. Other mice were killed 60 days after amputation.
Tumor rejection by CTL independent of perforin/FasL S-H Lee et al results (Fig 5a) show that target cell lysis by NK cells obtained from B6-PKO mice was completely abolished, indicating that NK cytotoxicity against the targets is dominantly induced by the perforin-mediated killing pathway. Although perforin-dependent killing seems to be dominant in NK, reduced NK activity was also monitored in splenocytes from B6-Smm mice, especially against D122 and its derivatives. Moreover, 39.5.1.11 target cell lysis by NK cells from C57BL/6 and B6-MRL mice was significantly reduced compared to parental D122 and 39.5-B7 cells. However, D122 target sensitivity to NK cells is statistically similar to 39.5-B7 cells. In agreement with previous reports, expression of MHC class I (K b ) inhibits NK activity through inhibitory receptors like the Ly49 family members, 26 while expression of B7-1 triggers NK activation. 27 
Generation of CTL in different mouse strains
Although CTL and NK act through peforin-and Fas/ FasL-mediated pathways in acute target cells lysis, it was also shown that other killing mechanisms, such as TNF-a and gIFN, play a critical role in controlling cytotoxicity in vitro and in vivo. 28, 29 We tested the possibility that other killing mechanisms independent of either perforin or Fas/ FasL would contribute to rejection of 39.5-B7 tumors in vivo. Since 39.5-B7 cells are sensitive to exogenous FasLexpressing cells, we could not exclude that 39.5-B7 local tumors in the mice were possibly eliminated through the FasL-mediated pathway of immune cells. CTL cytotoxicity from the mice (C57BL/6, B6-PKO and B6-Smn) implanted with 39.5-B7 cells were compared in 5 and 18 hours in vitro assays. Splenocytes were extracted 10 days after inoculation of 39.5-B7 tumor cells (1 Â 10 6 cells/ mouse), and effectors were resensitized and coincubated with [ 35 S]-labeled 39.5-B7 target cells in the presence of CMA, 30 an inhibitor of perforin-based cytotoxicity. The results (Fig 5b) show that 39.5-B7 cell lysis by CTLs obtained from B6-PKO mice is abrogated in a short-term (5 hour) assay. Consistently, when CMAtreated effectors from syngenic C57BL/6 or B6-Smn mice were incubated with the cells under the same conditions, cells lysis was completely abrogated compared with notreated and DMSO-treated CTL as controls. These results convincingly demonstrate that the perforin-mediated cytotoxicity by CTL is a dominant killing pathway in elimination of the 39.5-B7 cells for a short-term (5 hours) incubation (Fig 5b) . However, in an 18 hour assay, target lysis by effectors was markedly increased even when 39.5-B7 cells were coincubated with effectors in the presence of CMA. In addition, effectors that are treated with CMA from C57BL/6 and B6-Smn mice effectively induce in their target, 39.5-B7 cells, lysis with similar levels compared to B6-PKO mice. Thus, whereas the perforinmediated killing pathway by CTL is essentially required to induce target lysis for 5-hour incubation, other killing mechanisms that are not dependent on FasL or perforin play a major role in eliminating targets at a later time.
To examine the ability of 39.5-B7 transfectants to induce CTL generations, as well as the target sensitivity to CTL, CTL were prepared from mice immunized with irradiated 39.5-B7 cells. The cytotoxicity against parental D122 and the two transfectants was compared with that of CTL prepared from tumor-bearing mice as described in previous experiments. Effectors were prepared by restimulation with irradiated parental D122 or 39.5-B7 cells for 4 days. The effectors were co-incubated with [ 35 S]-labeled different target cells for 18 hours. The results (Fig  6) indicate that inoculation as well as immunization with 39.5-B7 cells strongly stimulate CTL responses in all mouse strains. Moreover, 39.5-B7 target lysis was effectively induced by all effectors. Abrogation of perforin and Fas/FasL expression in the host did not remarkably affect 39.5-B7 target lysis (Fig 6b, d) . In contrast, as we expected, CTL responses in mice both inoculated or immunized with parental D122 were lower. Anti-D122 CTL lysed D122 and 39.5.1.11 cells at low levels, but Tumor rejection by CTL independent of perforin/FasL S-H Lee et al 39.5-B7 cells were also effectively lysed by them (Fig 6a,  c) . Importantly, parental D122 cells were not eliminated by their effectors prepared from B6-PKO mice. Thus, unlike parental D122 cells, the high immunogenic 39.5-B7 cells can strongly elicit CTL responses. In addition, 39.5-B7 cells are lysed by CTL, in long-term assays, through a mechanism other than the mechanisms mediated by perforin and FasL.
In vivo depletion of CD8 T-cells and neutralization of TNF-a and gIFN
In order to verify which cell population is responsible for rejection of 39.5-B7 local tumors in vivo, in vivo depletion experiments were performed. Since perforin, gIFN and TNF-a were identified as critical pathways of effector mechanisms that characterize therapeutic anti-tumor T cells, 31 Hybridoma ascites containing specific antibodies against CD8, gIFN and TNF-a were intravenously injected into C57BL/6 and B6-PKO mice 1 day prior to inoculation of 39.5-B7 cells. Starting on day 6 after tumor cell inoculation, mice were further injected with hybridoma ascites weekly until local tumors were amputated. The results in Figure 7a Tumor rejection by CTL independent of perforin/FasL S-H Lee et al as well as to the prevention of metastasis. However, neutralization of gIFN and TNF-a activity using specific antibodies in vivo did not prevent rejection of the local tumors in the C57BL/6 and B6-PKO mice (Fig 7a) .
Initially, local tumors of B6-PKO mice injected with antibodies, including control IgM, developed, but the palpable tumors regressed 26 days after injection and were finally rejected. In contrast, local tumors in the mice depleted from CD8 T cells continuously developed.
In parallel, we also tested whether the antibodies can inhibit CTL cytotoxicity against 39.5-B7 target during in vitro assays. The results show that 39.5-B7 target lysis by C57BL/6 and B6-PKO derived effectors is significantly reduced compared to only effector cells and rat IgG groups in the presence of anti-CD8 antibodies (Fig 7b) . Moreover, neutralization of cytokines during CTL assays using the same anti-gIFN, and anti-TNF-a antibodies did not inhibit CTL activity (Fig 7c) . These results indicate that CD8 T-cells are directly responsible for rejection of 39.5-B7 tumors in the C57BL/6 and B6-PKO mice in vivo. Interestingly, elimination of 39.5-B7 cells by CD8 T-cells is not dependent on both TNF-a-and gIFN-mediated mechanisms in vivo.
Caspase-dependent apoptosis in tumor cells
Since it was reported that Fas/FasL-and perforin/ granzyme B-mediated pathways induce caspase-dependent as well as caspase-independent apoptosis in the cells, we studied whether caspase activation is required for lysis of 39.5-B7 cells by CTL. 13, 14, 32 Moreover, we wanted to examine which caspases have essential functions to induce apoptosis by CD8 T cells using caspase inhibitors.
CTL from C57BL/6 and B6-PKO mice immunized with irradiated 39.5-B7 cells were tested in 18 hour assays, in the presence and absence of the broad caspase inhibitors, z-VAD-fmk (50 mM) and inhibitors of caspase-8 (z-IETDfmk, 50 mM) or caspase-9 (z-LEHD-fmk, 50 mM) (Fig 8) . The results show partial inhibition of apoptosis mediated by C57BL/6 derived CTL and complete inhibition of apoptosis mediated by B6-PKO derived CTL in the presence of z-VAD-fmk. These results strongly suggest that caspase activation is required to induce 39.5-B7 cells lysis through the perforin-independent killing mechanism. However, target cell lysis involving a perforin-mediated killing pathway can also be induced without caspases activations. Besides in vitro assays, when DNA fragmen- Tumor rejection by CTL independent of perforin/FasL S-H Lee et al tations of 39.5-B7 target cells were tested after co incubation with CTL under the same conditions, we observed typical DNA ladders on gels, indicating that apoptotsis was induced in 39.5-B7 cells (data not shown). Transmission of apoptotic signals mediated by cell surface Fas receptor is mainly dependent upon activation of caspase-8 or caspase-9, which can be activated through molecules released from the mitochondria as an internal signal. We assumed that if Fas expression on 39.5-B7 cells has a crucial role in induced target cell lysis by CD8 T cells, CTL cytotoxicity against 39.5-B7 cells can be markedly inhibited in the presence of these caspase inhibitors in in vitro assays. 10, 33 However, incubation with 39.5-B7 cells in the presence of caspase-8 inhibitors (z-IETD-fmk) or caspase-9 inhibitors (z-LEHD-fmk) did not significantly inhibit CTL cytotoxicity (Fig 8) . Thus, CTL cytotoxicity mediated by the perforin-independent pathway does not involved the Fas/FasL-mediated killing mechanism, yet caspases activation is a prerequisite for the induction of 39.5-B7 cell lysis by CD8 T cells.
Discussion
We demonstrated, in the present study, that perforin expression by the host mainly contributes to prevention of spontaneous metastasis from the highly metastatic D122 local tumors. However, although 39.5-B7 cells were eliminated by the human FasL transfectants, abrogation of both perforin and Fas/FasL expression in the host did not affect rejection of 39.5-B7 tumors in vivo. These results suggest that immune cells can induce 39.5-B7 cell lysis through both perforin-and Fas/FasL-independent mechanisms. In addition, we showed that, whereas 39.5-B7 cell lysis by NK cells was dependent on perforin, coincubation with CTL obtained from C57BL/6, B6-PKO and B6-Smn mice in the presence of CMA could effectively eliminate 39.5-B7 cells in an 18 hour assay. The CTL cytotoxicity against 39.5-B7 cells was responsible for rejection of the tumor in vivo, but did not involve TNF-a-and gIFN-mediated cytotoxicity. Furthermore, the perforin independent CTL lysis of 39.5-B7 cells was blocked by the broad caspase inhibitor, z-VAD-fmk indicating that caspase activation in the cells was required to induce 39.5-B7 cell lysis by CTL through the perforinindependent cytotoxicity. However, caspase-8 and caspase-9 inhibitors did not markedly inhibit 39.5-B7 lysis. Thus, these results suggest that CD8 T-cells, which are activated by inoculation with H-2K b and B7-1 expressing tumor cells, contribute to rejection of 39.5-B7 local tumors in the mice. The CTL can induce apoptosis of their target through neither perforin-nor Fas/FasLmediated mechanisms, but caspase activation in the cells is needed to eliminate 39.5-B7 cells by the CTL.
Parental D122 cells were resistant to FasL-expressing cells due to lack of Fas expression on the cell surface. But, gIFN secreting D122 cells, DIF-2, can effectively enhance Fas expression and increase their sensitivity to FasLexpressing cells (Figs 1,2) . Unlike DIF-2 cells, levels of Fas expression on 39.5-B7 cells are not influenced by cell density, indicating that the slight increase in Fas expression on the cells resulted most probably from a cloning effect of the transfectants. Nevertheless, these results show that, in contrast to other tumors, the Fas-mediated apoptotic pathway on D122 cells is not blocked by inhibitors or is not defective (Fig 2) . Bergmann-Leitner and Abrams 34, 35 have compared lytic sensitivity of primary colon adenocarcinoma cells with that of metastatic colon tumor cells to an established CTL line after gIFN treatment of the tumor cells. In contrast to increased lytic sensitivity of primary colon tumor cells by Fas-dependent and -independent pathways, metastatic colon tumor cells were not sensitive to Fas-dependent cytotoxic activity, suggesting that the metastatic phenotype may be associated with resistance to Fas-mediated lysis in response to tumor-specific T-cells attack. Whether enhancement of Fas receptor expression on DIF-cells is directly related to increased immunogenicity should be further investigated.
NK lysis of target cells can be regulated by activatory and inhibitory signals. 36 Mouse NK function can be inhibited by Ly49 receptor families that are specific for classical MHC class I molecule on NK cells. 26 In this study, we can confirm previous reports demonstrating that B7-1 expressing target cells are more susceptible to NK lysis than nonexpressor cells. 27, 37 Here, our results show that, although levels of H-2K b on the 39.5-B7 transfectant are equivalent to the levels H-2K b on 39.5.1.11 cells, 39.5-B7 target cells were significantly more sensitive to NK lysis. This result indicates that B7-1 expression on NK target functions as an additional activation signal that overcomes reduced killing activity by H-2K b molecules (Fig 5) . Tumor rejection by CTL independent of perforin/FasL S-H Lee et al
Despite the fact that 39.5-B7 cells could be eliminated by FasL-expressing cells, effectors that were blocked in both peforin-and Fas/FasL-mediated killing could still effectively lyse their target cells in 18-hour assays. This observation is also supported by the fact that 39.5-B7 local tumors are rejected in both B6-PKO and B6-MRL/ Smn mice in vivo. Besides the two main killing pathways, it has been reported that other killing mechanisms, for example the proinflammatory cytokines gIFN and TNFa, have important roles in rejection of pulmonary metastasis of tumor cells. 38 In the study of Poehlein et al, 31 adoptive transfer of effector T cells, which are taken from perforin and gIFN double knockout mice (PKO/GKO), mediated complete tumor regression and cured wild-type animals with established pulmonary metastasis of melanoma cells by a TNF-a mediated killing mechanism. In addition, Smyth et al 39 have reported that, using the Renca carcinoma tumor model, TRAIL expression on NK and NKT cells has effective antimetastatic functions in vivo mediated by a gIFNdependent immune mechanism. In contrast to the tumor models used in previous studies, we demonstrated here that the high metastatic Lewis lung carcinoma clone, D122 cells were not sensitive to Fas or TRAIL-mediated apoptotic pathways. Perforin expression plays a major role in protection of the host from tumor progression, as well as in the kinetics of spontaneous metastasis. But, 39.5-B7 cells, which are high immunogenic cells expressing both H-2K b and B7-1(CD80), could be rejected in C57BL/6 and B6-PKO mice neutralized with anti-TNF-a and anti-gIFN antibodies, but not in mice depleted from CD8 T cells (Fig 7) . These results indicated that TNF-aor gIFN-mediated cytotoxic mechanisms did not play an important function in rejection of tumors by CD8 T cells in vivo. In vitro assays, using antibodies that were used for in vivo experiments, confirmed that cytokine-mediated cytotoxicity was not involved in 39.5-B7 cells lysis by CD8 T cells. Except these killing mechanisms, what kind of cytotoxic activity can potentially be responsible for elimination of the target cells? We can suggest several possibilities to interpret our main observations. Kozlowski et al 40 have shown that expression of a cytolytic molecule, designed NKLAM (NK lytic associated molecule), can be upregulated in NK, CTL and macrophage that are activated by the cytokine IL-2. Therefore, we can hypothesize that B7-1 costimulation on the cells could indirectly amplify CTL lytic functions by producing sufficient amount of various cytokines that can upregulate expression of cytolytic molecules on the effectors. It has been reported that other cytotoxic molecules that are constituted in a granule, for example granulysin, 41 can be involved in the perforin-independent CTL killing. 42 Moreover, since granzyme B can directly enter target cells by a receptor, without the involvement of perforin, the cells can be induced to undergo apoptosis by both perforin-and FasL-independent pathways. 43 Another interesting observation was that, while caspase activation was only partially required to induce 39.5-B7 lysis by perforin-mediated cytotoxicity, perforin-independent CTL lysis of 39.5-B7 cells required caspase activation to transmit death signals to the cells. Malyguine et al 44 have reported that the caspase inhibitor zVAD-fmk had no or significantly lower effect on B6-Smn T-cells cytotoxicity against A20 cells. In contrast, the same concentrations of zVAD-fmk practically blocked the lytic activity of B6-PKO mice T cells. This observation strongly suggests that perforin-independent apoptotic pathways mediated by CTL are different from the perforin-mediated lytic mechanisms. It might be necessary to further investigate how perforin-independent lytic activity can be triggered to induce target lysis by CTL.
In summary, we demonstrated, in this study, that whereas perforin-mediated cytotoxicity has a dominant function in elimination of highly metastatic D122 cells, the H-2K b and B7-1 transfected D122, 39.5-B7 cells were sensitive to CTL killing through neither perforin nor Fas/ FasL-mediated lysis. Caspase activation was required to elicit cell lysis by CTL. Furthermore, this perforin-and FasL-independent lytic activity by CD8 T cells played a major role in rejection of 39.5-B7 cells in vivo.
